Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - Riot Blockchain, Inc.ex99x1.htm
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported) September 19, 2016
 
 
 
Venaxis, Inc.
 
 
 
(Exact name of Registrant as specified in its charter)
 
 
 
 
Colorado
 
001-33675
 
84-155337
(State or other jurisdiction of incorporation or organization)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)
 
1585 South Perry Street
Castle Rock, Colorado
 
80104
(Address of principal executive offices)
 
(Zip Code)
 
Registrant's telephone number, including area code:
 
(303) 794-2000
 



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




 
Item 7.01 Regulation FD Disclosure.
Stephen Lundy, the President and Chief Executive Officer of Venaxis, Inc., a Colorado corporation (the "Company") is providing the attached letter to the shareholders of the Company.  The letter to shareholders attached as Exhibit 99.1 to this Form 8-K is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following exhibit is furnished herewith:
Exhibit No.
Document
   
99.1
Venaxis, Inc. Letter to Shareholders, dated September 19, 2016.

 
 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
Venaxis, Inc.
 
   
By:
 
/s/ Jeffrey McGonegal
 
 
Name:
 
Jeffrey McGonegal
 
 
Title:
 
Chief Financial Officer
Date: September 19, 2016





EXHIBIT INDEX
Exhibit No.
Document
   
99.1
Venaxis, Inc. Letter to Shareholders, dated September 19, 2016.